Type I

Societal Factors Drive Diabetes Complications

Two large studies say that the risk of serious diabetes complications isn’t merely driven by an individual’s blood sugar control. Instead, multiple factors, which can include body mass index (BMI), age, gender, and socio-economic factors like income level, insurance coverage and education can affect a person’s risk of developing complications like diabetic neuropathy and cardiac […]

Immunosuppressive Medication Shows Potential for Type 1 Treatment

Golimumab is a human antibody that is used as an immunosuppressive drug (brand name Simponi) and is approved for the treatment of several autoimmune conditions, including ulcerative colitis. Researchers investigated whether golimumab could preserve beta-cell function in young people newly diagnosed with type 1 diabetes. Read more

Hybrid Closed-Loop Systems and Insulin Variability in Children

Young children with type 1 diabetes often have greater insulin variability than do adults, which can lead to more complications and quality of life issues. Researchers investigated whether hybrid closed-loop devices, which deliver insulin automatically by using an algorithm that sensors glucose values in real-time, can help. Read more

Type 1 Can Affect Children’s Cognitive Development

Because children’s brains are growing, they are more susceptible to interference with glucose production and metabolic breakdown, which has several adverse effects. Glucose in the brain is essential to its proper functioning, as the brain requires glucose to incite and feed brain cells. Read more

Mental Health: Type 1 and “Diabetes Burnout”

Many people who have been diagnosed with type 1 diabetes are overwhelmed by the daily physical and mental challenges of managing the condition. This can result in “diabetes burnout,” a dangerous condition where patients are so overwhelmed they neglect to manage their insulin, glucose testing and food choices adequately. Read more

Precision Medicine Achieves Type 1 Reversal

A precision medicine treatment has led to the reversal of a case of type 1 diabetes in a male patient, says a study published in the New England Journal of Medicine. The researchers found the patient had a harmful mutation in a gene called STAT1, and treated the patient with a drug that could inhibit […]

Challenges for Young Diabetes Patients Moving from Pediatric To Adult Care

Adolescents and young adults age 17-23 who have type 1 diabetes are at high risk for negative health outcomes, including poor glycemic control, as they move from pediatric and parental care to independent self-care skills and preparation for adult diabetes care. Researchers are examining how improved communication between young people and health care providers can […]

New International Guidelines for Safe Exercise with Type 1

An international team of experts have laid out the world’s first standard guidance on how people with diabetes can use modern glucose monitoring devices to help them exercise safely. The guidance can be used by healthcare professionals around the world to help people with type 1 diabetes. Read more

Which Type 1 Patients will Experience Partial Remission?

Doctors know that a certain percentage of people with type 1 diabetes will experience what’s called a “partial remission,” after being diagnosed and started on insulin therapy. Partial remission is a period of time in which the patient’s beta–cell function will temporarily be restored. Researchers are seeking to understand what determines which patients will experience this partial […]

Diabetes Shortens Lifespans

A new data modelling study says that the average person with type 1 diabetes in the UK today will live almost eight years less than an average person who does not have diabetes, while those with type 2 diabetes will live almost 2 years less than a person without type 2. Read more

Type 1 Diabetes Damages Teens’ Working Memory

Type 1 diabetes can affect young patients in many ways. A recent study found that exposure to glycemic extremes can have a negative impact on healthy brain development and cognitive function, including spatial working memory, in teenagers.  Read more

Type 1 Diabetes Diagnoses Delayed by COVID-19

The coronavirus pandemic may have delayed diabetes diagnoses for many children with type 1, according to Italian researchers studying how diabetes diagnoses in 2020 have compared to historic data. Read more

Artificial Pancreas Can Help Children as Young as Six

A new study published in the New England Journal of Medicine found that an artificial pancreas system, using a continuous glucose monitoring (CGM) device and a separate insulin pump, was safe and beneficial in children with type 1 diabetes who were as young as six years of age. Read more

Insulin Challenges for Many Amid COVID-19 Pandemic

People with diabetes are at higher risk for complications of COVID-19, and good diabetes management is key for maximizing health and reducing risk. But for many with type 1, obtaining insulin is a challenge due to job and health insurance losses in the pandemic. Read more

CGM for Pregnant Women with Type 1

For pregnant women with type 1 diabetes, their maternal glucose levels play a large role in determining fetal growth. Continuous glucose monitoring (CGM) allows expecting mothers to assess the changes in their blood glucose levels. Read more

A “Do-It-Yourself” Artificial Pancreas

Do-it-yourself artificial pancreas systems (DIYAPS) were developed by members of the diabetes community to offer a solution to type 1 diabetes patients who can’t access or afford other tech systems. Read more

AI to Help People with Type 1 Manage Glucose

Researchers have used artificial intelligence (AI) to develop an algorithm that gives people weekly guidance on managing their type 1 diabetes, based on data from a continuous glucose monitor, insulin pens, and a wearable device to monitor physical activity. The algorithm also uses a smartphone app called DailyDose. Read more

Exercising and Managing Insulin with Type 1

Balancing blood glucose levels during (and after) exercise with type 1 diabetes is key if you want to be successful at being physically active as an insulin user, and want to prevent hypoglycemia or hyperglycemia during exercise. Diabetes exercise expert Dr. Sheri Colberg shares some tips for managing insulin, food, and exercise. Read more

Preventing Type 1 May Become a Reality

Teplizumab may become the first antibody commercially available that can halt or delay the progression of type 1 diabetes. Researchers have found that a single 14-day infusion of teplizumab leads to a median 3-year delay in type 1 diabetes onset in high-risk individuals. Read more

Consumer Advocacy Group Wants SGLT-2 Warnings for Type 1 Patients

Public Citizen, a consumer advocacy group, is urging the FDA to strengthen its warnings that SGLT-2 inhibitors are associated with increased risk of diabetic ketoacidosis, due to hundreds of cases of this potentially fatal condition in people with type 1 diabetes. SGLT-2 inhibitors are not currently approved for use in type 1 diabetes in the […]